Do Artemisia annua L. compounds have SARS-CoV-2 antiviral potential?

Caused by SARS-CoV-2, the ongoing COVID-19 pandemic has led to over 121.2 million cases and over 2.6 million deaths worldwide. An interesting new study examines the potential antiviral activity of compounds present in the plant Artemisia annua L.

Frontiers Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents

A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Frontiers Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

The direct and indirect effects of bioactive compounds against coronavirus - Tomas - 2022 - Food Frontiers - Wiley Online Library

Life, Free Full-Text

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)

Biologics, Free Full-Text

IJMS, Free Full-Text